SEC Form 4 · accession 0001225208-19-004350
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maulik Nanavaty
Officer — SVP & Pres, Neuromodulation
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 25, 2019 | G | 1,700 | $0.00 | D | 253,648 | D | |
| Common StockF2,F1 | Feb 28, 2019 | M | 1,629 | $0.00 | A | 255,277 | D | |
| Common StockF1 | Feb 28, 2019 | F | 808 | $40.12 | D | 254,469 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF2,F3 | — | Feb 28, 2019 | M | 1,629 | D | — | Feb 28, 2022 | Common Stock | 1,629 | 4,888 | D |
Explanation of responses
- F1Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F2Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F3Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.